Related Experiment Video
Updated: Mar 2, 2026

Multidimensional Coculture System to Model Lung Squamous Carcinoma Progression
Published on: March 17, 2020
RhoA inhibits apoptosis and increases proliferation of cultured SPCA1 lung cancer cells
Dabei Liu1, Xingke Mei1, Linlin Wang1
1Department of Thoracic Surgery, The Fourth Affiliated Hospital of China Medical University, Shenyang, Liaoning 110032, P.R. China.
Abstract:
The Rho kinase pathway has previously been reported to possess a close relationship with the growth, migration and invasion of lung cancer cells. However, the molecular mechanisms underlying the effects of this pathway on lung cancer cells are still elusive. The aim of the present study was to investigate the effects and underlying molecular mechanisms of Ras homolog family member A (RhoA) on the proliferation and apoptosis of SPCA1 lung carcinoma cells. Stable SPCA1 lung cancer cell lines, in which RhoA expression was silenced by small interfering RNA, were isolated following Geneticin screening. Inhibition of RhoA expression significantly decreased the proliferation of SPCA1 lung cancer cells, whereas apoptosis was significantly increased (P<0.01) as determined by the MTS tetrazolium assay and flow cytometry analysis, respectively. At the molecular level, knockdown of RhoA resulted in the significant activation of caspase‑3 (P<0.01), and a significant reduction in the levels of phosphorylated signal transducer and activator of transcription (phospho‑STAT3; P<0.01), as determined by western blotting. The results suggested that RhoA knockdown prevents cell proliferation and induces apoptosis in SPCA1 lung cancer cells. Furthermore, the underlying mechanisms responsible for these effects may include the activation of caspase‑3 and the reduction of phospho‑STAT3 levels.
Insights
Ras homolog family member A (RhoA) knockdown inhibits lung cancer cell proliferation and promotes apoptosis. This occurs through caspase-3 activation and reduced phospho-STAT3 signaling in SPCA1 cells.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- The Rho kinase pathway is implicated in lung cancer progression.
- Molecular mechanisms linking RhoA to lung cancer cell behavior remain unclear.
Purpose of the Study:
- To investigate the effects of Ras homolog family member A (RhoA) on SPCA1 lung carcinoma cell proliferation and apoptosis.
- To elucidate the underlying molecular mechanisms of RhoA's action in lung cancer.
Main Methods:
- Small interfering RNA (siRNA) was used to silence RhoA expression in SPCA1 cells.
- Cell proliferation was assessed using the MTS tetrazolium assay.
- Apoptosis was quantified via flow cytometry.
- Western blotting was employed to analyze caspase-3 and phospho-STAT3 levels.
Main Results:
- RhoA knockdown significantly decreased SPCA1 cell proliferation.
- RhoA inhibition led to a significant increase in SPCA1 cell apoptosis (P<0.01).
- Molecular analysis revealed significant activation of caspase-3 and reduction of phospho-STAT3 in RhoA-silenced cells (P<0.01).
Conclusions:
- RhoA knockdown effectively inhibits proliferation and induces apoptosis in SPCA1 lung cancer cells.
- The observed effects are associated with caspase-3 activation and decreased phospho-STAT3 levels.
- RhoA represents a potential therapeutic target for lung cancer treatment.
More Related Videos
09:19Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
Published on: February 6, 2015
13:59A Quantitative Measurement of Reactive Oxygen Species and Senescence-associated Secretory Phenotype in Normal Human Fibroblasts During Oncogene-induced Senescence
Published on: August 12, 2018
Related Concept Videos
Abnormal Proliferation
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
The Ras Gene
Ras is a...
The Intrinsic Apoptotic Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...